{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0000", "char_start": 0, "char_end": 2000, "pages": [1], "text": "June 2019\nVolume 35 | Number 7\nMedicaid Coverage of Limited Infertility Benefit\nEffective October 1, 2019, Medicaid fee-for-service (FFS) and Medicaid Managed Care (MMC) benefits will\ninclude medically necessary ovulation enhancing drugs and medical services related to prescribing\nand monitoring the use of such drugs for individuals 21 through 44 years of age experiencing infertility.\nThis applies to MMC plans, including mainstream MMC plans, HIV Special Needs Plans (HIV SNPs), and\nHealth and Recovery Plans (HARPs). FFS and MMC infertility benefits include office visits,\nhysterosalpingograms, pelvic ultrasounds, blood testing, and ovulation enhancing drugs included in the\nMedicaid formulary.\nThe ovulation enhancing drugs included in the Medicaid formulary are bromocriptine, clomiphene\ncitrate, letrozole, and tamoxifen. FFS and MMC infertility benefits will be limited to coverage for three (3)\ncycles of treatment per lifetime. For Medicaid purposes, infertility is a condition characterized by the incapacity\nto conceive, defined by the failure to establish a clinical pregnancy after twelve (12) months of regular,\nunprotected sexual intercourse for individuals 21 through 34 years of age, or after six (6) months for individuals\n35 through 44 years of age.\nMedicaid FFS claims\nProfessional and institutional claims submitted to eMedNY for infertility services must include the appropriate\ninfertility diagnosis code and the family planning indicator (“A4” condition code on institutional claims or a “Y”\nin the family planning box on professional claims). General billing guidelines can be accessed online at the\ncorresponding link below:\n• Institutional\nhttps://www.emedny.org/ProviderManuals/AllProviders/General_Billing_Guidelines_Institutional.pdf\n• Professional\nhttps://www.emedny.org/ProviderManuals/AllProviders/General_Billing_Guidelines_Professional.pdf\nQuestions:\n• Medicaid FFS coverage and policy questions may be directed to the Office of Health Insurance Programs\n(OHIP),", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0001", "char_start": 1750, "char_end": 3750, "pages": [1, 2], "text": "nstitutional.pdf\n• Professional\nhttps://www.emedny.org/ProviderManuals/AllProviders/General_Billing_Guidelines_Professional.pdf\nQuestions:\n• Medicaid FFS coverage and policy questions may be directed to the Office of Health Insurance Programs\n(OHIP), Division of Program Development and Management at (518) 473–2160.\n• Medicaid MMC general coverage questions may be directed to OHIP, Division of Health Plan Contracting\nand Oversight at covques@health.ny.gov or (518) 473–1134.\n• MMC reimbursement and/or billing requirements questions may be directed to the enrollee’s MMC plan.\nAn MMC directory by plan can be found on the New York State Department of Health's web site at:\nhttps://www.health.ny.gov/health_care/managed_care/plans/docs/mcp_dir_by_plan.pdf.\n• Questions regarding FFS claiming may be directed to the eMedNY Call Center at (800) 343–9000.\n\nAndrew M. Cuomo\nGovernor\nState of New York\nHoward A. Zucker, M.D., J.D.\nCommissioner\nNew York State\nDepartment of Health\nDonna Frescatore\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nMedicaid Coverage of Limited Infertility Benefit ............................................................................................................... Cover\nPolicy and Billing\nAttention Physicians, Nurse Practitioners, and Ordered Ambulatory Providers: Billing Update for Bacillus\nCalmette-Guerin Intravesical ................................................................................................................................................... 3\nPolicy Clarification: Medical Marijuana ................................................................................................................................... 4\nPharmacy\nPharmacy Fee-for-Service Billing Guidance: Long Term Care and Foster Care (Child Care) Facilities ............................... 5\nAll Providers\nReminder: Safeguarding Electronic Prescribing Cre", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0002", "char_start": 3500, "char_end": 5500, "pages": [2, 3], "text": "........................................... 4\nPharmacy\nPharmacy Fee-for-Service Billing Guidance: Long Term Care and Foster Care (Child Care) Facilities ............................... 5\nAll Providers\nReminder: Safeguarding Electronic Prescribing Credentials - Practitioner Responsibilities ................................................... 7\nReminder: Authorized Agents for Prior Authorizations of Prescription Drugs ....................................................................... 8\nBreastfeeding Grand Rounds 2019: Breastfeeding Recommendations for Women Impacted by Opioid Use Disorder\nand Infants with Neonatal Abstinence Syndrome .................................................................................................................. 8\n2019 Medicaid Managed Care Primary Care Providers, Access and Availability ................................................................. 9\nNew York Medicaid EHR Incentive Program ....................................................................................................................... 10\nProvider Directory......................................................................................................................................................... 12\nJune 2019 New York State Medicaid Update pg. 2\n\nPolicy and Billing\nAttention Physicians, Nurse Practitioners, and Ordered Ambulatory\nProviders: Billing Update for Bacillus Calmette-Guerin Intravesical\nEffective July 1, 2019, providers billing for Bacillus Calmette-Guerin (BCG) intravesical must use code “J9030:\nBCG LIVE INTRAVESICAL,1 MG”. Due to the current BCG (intravesical) drug shortage, providers in Medicaid\nfee-for-service (FFS) and Medicaid Managed Care (MMC) can use “J9030” to bill for single or multiple patient\nuse of the single-use vial effective for dates of service on or after July 1, 2019.\nProviders who opt to treat multiple patients using the single-use vial must adhere to the New York State\nDepartment of Health’s Health Advisory: BC", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0003", "char_start": 5250, "char_end": 7250, "pages": [3], "text": "r multiple patient\nuse of the single-use vial effective for dates of service on or after July 1, 2019.\nProviders who opt to treat multiple patients using the single-use vial must adhere to the New York State\nDepartment of Health’s Health Advisory: BCG Live (Intravesical) shortage: Use of single-use vials for multiple\npatients, which can be found on the New York Health Commerce System website at:\nhttps://commerce.health.state.ny.us. In accordance with the Health Advisory, providers practicing in both Article\n28 and non-Article 28 locations who will share single-use vials of BCG for multiple patients during this current\nshortage must take the following precautions:\n1. Ensure that written protocols are readily available for all staff who will be involved in the reconstitution,\nadministration, and disposal of BCG and related equipment. Ensure that these written protocols are\nbased on the manufacturer’s instructions and the Center for Disease Control’s (CDC) safe injection\npractices guidelines except for the restriction on reuse of single-use vials.\n2. Ensure that all staff who prepare and administer BCG are doing so within the scope of their professional\npractice and are supervised by a physician.\n3. Ensure that this interim practice of sharing single-use vials of BCG is not allowed for any other medication\nand ensure that this interim practice does not continue after the shortage is resolved.\n4. Ensure that other issues surrounding the practice of using a single-use vial for more than one patient,\nsuch as billing/insurance issues, have been adequately addressed.\nFee-for-Service Billing Guidance:\nSingle patient use\n• If the entire single-use vial is administered to a single patient, bill for the entire vial\n• If a portion of the single-use vial is administered to a single patient and the remaining drug is discarded,\nbill for the actual dose administered (per mgs) and for the waste (modifier JW). Please refer to the May\n2016 Medicaid Update article titled “Updated Guidan", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0004", "char_start": 7000, "char_end": 9000, "pages": [3, 4], "text": " the single-use vial is administered to a single patient and the remaining drug is discarded,\nbill for the actual dose administered (per mgs) and for the waste (modifier JW). Please refer to the May\n2016 Medicaid Update article titled “Updated Guidance and Clarification on Use of the JW Modifier” for\nadditional information.\nMultiple patient use\nIf a single-use vial is utilized for multiple patients, bill for the actual administered drug (per mgs) only.\nPayment for drugs furnished by practitioners to their patients is based on the acquisition cost to the practitioner\nof the drug dose administered to the patient. For all drugs furnished in this fashion, it is expected that the\npractitioner will maintain auditable records of the actual itemized invoice cost of the drug, including the number\nof doses of the drug represented on the invoice. Refer to: www.emedny.org for additional information.\nQuestions:\n• FFS coverage and policy questions may be directed to the Office of Health Insurance Programs (OHIP)\nDivision of Program Development and Management at (518) 473-2160.\n• MMC general coverage questions may be directed to OHIP Division of Health Plan Contracting and\nOversight at: covques@health.ny.gov or (518) 473-1134.\n• MMC reimbursement and/or billing requirement questions should be directed to the enrollee’s MMC plan.\n• FFS claim questions should be directed to the eMedNY call center at (800) 343-9000.\n• BCG Single-use vial health advisory questions should be directed to the Department of Health Bureau of\nHealthcare Associated Infections at: icp@health.ny.gov or (518) 474-1142.\nJune 2019 New York State Medicaid Update pg. 3\n\n*******************************************************************************************************************\nPolicy Clarification – Medical Marijuana\nMedical marijuana is not a covered benefit under Medicaid. However, practitioner office visits related to patient\nevaluation and certification for medical marijuana is a Medicaid reimbursable se", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0005", "char_start": 8750, "char_end": 10750, "pages": [4, 5], "text": "**************\nPolicy Clarification – Medical Marijuana\nMedical marijuana is not a covered benefit under Medicaid. However, practitioner office visits related to patient\nevaluation and certification for medical marijuana is a Medicaid reimbursable service. New York State Medicaid\nhas reason to believe that providers may be scheduling a follow-up visit solely for certification, and this visit is\nbeing billed to the patient on a private pay basis. Patient evaluation and certification for medical marijuana is\nconsidered a comprehensive array of services and cannot be fragmented. Payment for the practitioner\ncertification is included in Medicaid’s payment for the office visit. Practitioners are therefore prohibited from\nrequesting payment for medical marijuana certification from the member, regardless whether the certification is\nprovided during the initial office visit or subsequent to the initial visit.\nQuestions on this matter may be directed to the Division of Program Development and Management, Office of\nHealth Insurance Programs, at 518-473-2160.\n*******************************************************************************************************************\nJune 2019 New York State Medicaid Update pg. 4\n\nPharmacy\nPharmacy Fee-for-Service Billing Guidance: Long Term Care\nand Foster Care (Child Care) Facilities\nAll pharmacy claims included in the rate must be billed to the facility. Information on long term care (LTC)\npharmacy claims can be found in the June 2011 Special Edition Medicaid Update. Information regarding Foster\nCare (FC) pharmacy claims can be found at: https://www.health.ny.gov/health_care/medicaid/program/\ncarveout.htm. The following process is necessary to successfully bill pharmacy claims that are not covered in\nthe rate by identifying and billing the appropriate coverage. Additionally, this guidance must be followed prior to\nsending New York State Medicaid requests for retroactive claim overrides.\nThird-Party Liability (TPL) and Medicaid Eligibi", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0006", "char_start": 10500, "char_end": 12500, "pages": [5], "text": " covered in\nthe rate by identifying and billing the appropriate coverage. Additionally, this guidance must be followed prior to\nsending New York State Medicaid requests for retroactive claim overrides.\nThird-Party Liability (TPL) and Medicaid Eligibility Coverage\nDetermine eligibility coverage by use of any and all resources available including:\n• The facility billing office;\n• Medicaid Eligibility Verification System (MEVS) & TPL\n(https://www.emedny.org/ProviderManuals/5010/MEVS%20Quick%20Reference%20Guides/5010_ME\nVS_Methods.pdf); and/or\n• ePACES (https://www.emedny.org/epaces/).\nProviders should check for TPL and eligibility coverage updates at least twice monthly following first date of\nservice (DOS). New York State Medicaid is always the payor of last resort; every effort must be taken to\nobtain correct billing information.\nIf TPL is applicable, providers must the third-party insurer first, including commercial plans or Medicare,\nand bill Medicaid as secondary, if appropriate. Any claim issues must be resolved with the third-party insurer,\nincluding prior authorization (PA) requirements, prior to submitting the claim to Medicaid. Note: If the primary\ninsurer does not cover a specific medication, Medicaid will not cover the claim. Failure to submit the claim to the\nthird-party insurer will result in denial of the claim by Medicaid.\nIf the member has Medicare, providers will bill:\n• Medicare Part B for Part B covered drugs. Information on Part B covered drugs can be found at:\nhttps://www.medicare.gov/what-medicare-covers/what-part-b-covers, or\n• Medicare Part D for other prescription drugs. Information on Part D covered drugs can be found at:\nhttps://www.medicare.gov/drug-coverage-part-d.\nIf the member has Medicare Parts A or B (or both) and does not have Medicare Part D, providers will bill:\n• Part D covered claims to Medicare Limited Income Newly Eligible Transition (LINET). Information on\nLINET can be found at: https://www.cms.gov/Medicare/Eligibility-and-Enro", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0007", "char_start": 12250, "char_end": 14250, "pages": [5, 6], "text": "rts A or B (or both) and does not have Medicare Part D, providers will bill:\n• Part D covered claims to Medicare Limited Income Newly Eligible Transition (LINET). Information on\nLINET can be found at: https://www.cms.gov/Medicare/Eligibility-and-Enrollment/LowIncSubMedicare\nPresCov/MedicareLimitedIncomeNET.html. Initiating Medicare Part D enrollment by utilizing LINET at\nfirst DOS will facilitate payment of claims.\nBilling Claims That Require Medicaid Prior Authorization (PA)\nFor members whose active eligibility status began after the date the pharmacy service was provided (retroactive\nbilling):\n• If date of notification of eligibility is within 90 days of DOS, call Magellan Health, Inc. at 877-309-9493.\nContact can also be made at: https://newyork.fhsc.com/contactus.asp.\n• If date of notification of eligibility is after 90 days of DOS, LTC/FC facility pharmacies may send the claim\ninformation for retro-PA consideration, within 30 days from the date of notification of eligibility, to the\nMedicaid Pharmacy unit at PPNO@health.ny.gov. All claims submitted for PA after 30 days of\neligibility determination will be denied. Additional information on submitting claims over 90 from DOS\nJune 2019 New York State Medicaid Update pg. 5\n\ncan be found at: https://www.emedny.org/HIPAA/QuickRefDocs/FOD-7001_Sub_Claims_Over_90_\ndays_Old.pdf.\n• Any claim submitted with a DOS after the date of notification of eligibility will be denied. The claim should\nhave been billed on the DOS.\nReminders:\n• It is the responsibility of the providers, both the facility as well as the pharmacy, to actively and\nregularly seek TPL enrollment and Medicaid eligibility for their members.\n• It is the pharmacy’s responsibility to bill timely and to the appropriate party, which may include the facility,\ncommercial plan, Medicare, or Medicaid. Additional information regarding timely billing can be found at:\nhttps://www.emedny.org/ProviderManuals/AllProviders/Guide_to_Timely_Billing.pdf.\n• All pharmacies must ", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0008", "char_start": 14000, "char_end": 16000, "pages": [6], "text": "te party, which may include the facility,\ncommercial plan, Medicare, or Medicaid. Additional information regarding timely billing can be found at:\nhttps://www.emedny.org/ProviderManuals/AllProviders/Guide_to_Timely_Billing.pdf.\n• All pharmacies must submit their transactions through the online Prospective Drug Utilization Review\n(Pro-DUR) program using the National Council for Prescription Drug Programs (NCPDP) transaction\nformat. NCPDP format specifications can be found in the MEVS Manual available at:\nhttps://www.emedny.org/ProviderManuals/5010/MEVS/MEVS_DVS_Provider_Manual_(5010).pdf.\n• All pharmacy claims are subject to Medicaid Pharmacy Program requirements, including PA and criteria\nrequirements. Additional information on program requirements can be found at: https://newyork.\nfhsc.com/downloads/providers/NYRx_PDP_PDL.pdf.\n• Upon claims submission, if the member is determined ineligible, the Pro-DUR transaction will adjudicate.\nIf a PA message is received that states: \"UNABLE TO PROCESS A PHARMACY PA PLEASE CALL\nMAGELLAN\" the pharmacy should alert the prescriber, at first and every occurrence, to align medication\ntherapy with the Preferred Drug Program (PDP) when appropriate. Additional information on the PDP\ncan be found at: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf. This is the\nappropriate time to explore non-PA alternatives and facilitate payment. A PA will not be issued by the\nclinical call center for a patient who is ineligible.\n• Original prescriptions must be filled within 60 days (30 days for controlled substances) of prescriber\nwritten/order date; a system edit will deny claims beyond this limitation. The same drug/strength/quantity,\n(i.e., prescription) cannot have more than one prescription number per same written date. Bypassing\nthe edit by giving a refill a new prescription number and new written date is considered fraudulent\nbilling and subject to audit.\nData Definitions:\n• Eligibility Date – the date that begins active eligibi", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0009", "char_start": 15750, "char_end": 17750, "pages": [6, 7], "text": "ption number per same written date. Bypassing\nthe edit by giving a refill a new prescription number and new written date is considered fraudulent\nbilling and subject to audit.\nData Definitions:\n• Eligibility Date – the date that begins active eligibility status.\n• Date of Notification of Eligibility – the date eligibility was updated or activated in the Medicaid system.\nJune 2019 New York State Medicaid Update pg. 6\n\nAll Providers\nReminder: Safeguarding Electronic Prescribing Credentials-\nPractitioner Responsibilities\nPursuant to New York State (NYS) Public Health Law §3302(37), an electronic prescription means “a prescription\nissued with an electronic signature and transmitted by electronic means in accordance with regulations of the\ncommissioner of health and the commissioner of education and consistent with federal requirements.”\nFederal requirements in Title 21 of the Code of Federal Regulation (CFR) §1311.102, Practitioner\nresponsibilities, require that in order to electronically prescribe controlled substances:\n(a) The practitioner must retain sole possession of the hard token, where applicable, and must\nnot share the password or other knowledge factor, or biometric information, with any other\nperson. The practitioner must not allow any other person to use the token or enter the knowledge\nfactor or other identification means to sign prescriptions for controlled substances. Failure by\nthe practitioner to secure the hard token, knowledge factor, or biometric information may provide\na basis for revocation or suspension of registration pursuant to §304(a)(4) of the Act (21 U.S.C.\n824(a)(4)).\n(b) The practitioner must notify the individuals designated under §1311.125 or §1311.130 within\none business day of discovery that the hard token has been lost, stolen, or compromised or the\nauthentication protocol has been otherwise compromised. A practitioner who fails to comply with\nthis provision may be held responsible for any controlled substance prescriptions written us", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0010", "char_start": 17500, "char_end": 19500, "pages": [7, 8], "text": "t the hard token has been lost, stolen, or compromised or the\nauthentication protocol has been otherwise compromised. A practitioner who fails to comply with\nthis provision may be held responsible for any controlled substance prescriptions written using\nhis two-factor authentication credential.\nThe Federal Requirements for Electronic Orders and Prescriptions, in full, can be accessed online at:\nhttps://www.deadiversion.usdoj.gov.\nFailure to meet these requirements may be considered an unacceptable practice under Title 18 of the New York\nCodes, Rules, and Regulations Part 515 (18 NYCRR §515.2). Providers who fail to meet these requirements\nmay be subject to sanction by the Office of the Medicaid Inspector General (OMIG), as defined under Title 18 of\nthe NYCRR §515.3, which may include censure or exclusion from the NYS Medicaid program.\nOMIG is an independent office within the New York State Department of Health (DOH). OMIG is responsible for\nthe investigation, detection, and prevention of Medicaid fraud, waste and abuse, including sanctioning providers\nand recovering overpayments in the Medicaid program.\nApplicable NYS laws, regulations, rules and policies of the Medicaid program are set forth in NYS Public Health\nLaw, NYS Social Services Law, the regulations of DOH (Titles 10, 14, and 18 of the NYCRR), DOH’s Medicaid\nProvider Manuals and Medicaid Update publications. Additional information can be found on the OMIG’s website\nat https://www.omig.ny.gov.\n*******************************************************************************************************************\nJune 2019 New York State Medicaid Update pg. 7\n\nReminder: Authorized Agents for Prior Authorizations of\nPrescription Drugs\nHealth care providers are required to complete the prior authorization (PA) process for various reasons, including\nprescribing a drug for which there is an equally effective lower cost alternative, safety concerns, and/or a potential\nfor inappropriate use. In all cases, prescribers wi", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0011", "char_start": 19250, "char_end": 21250, "pages": [8], "text": "to complete the prior authorization (PA) process for various reasons, including\nprescribing a drug for which there is an equally effective lower cost alternative, safety concerns, and/or a potential\nfor inappropriate use. In all cases, prescribers will need to provide their clinical rationale for why the drug should\nbe covered. Only the prescriber or the authorized agent may initiate the PA request for both Medicaid fee-\nfor-service (FFS) and Medicaid Managed Care (MMC) Plans. PA requests for FFS members need to be\napproved and validated through the Clinical Call Center at 1-877-309-9493. Providers should contact the MMC\nPlan for information on how to obtain a PA for MMC members.\nAuthorized Agent Requests:\n• An authorized agent is an employee of the prescribing practitioner who has access to the patient’s\nmedical records; for example, a nurse or medical assistant.\n• Pharmacists can only initiate PAs for an emergency 72-hour supply (5-day supply for medications to\ntreat substance use disorders) when an emergency condition exists. An emergency condition is a\ncondition that places the health or safety of the person afflicted with such condition or other person(s) in\nserious jeopardy.\nThird party requests are prohibited; prescribers may not contract with or assign authority to dispensing\npharmacists, manufacturers, or other persons or companies to initiate their PA requests.\nThe member must be given a choice of where to get their medications or supplies. Federal law prohibits limiting\na Medicaid beneficiary’s freedom of choice except under certain circumstances including but not limited to\nrecipient restriction (§1902(a)(23) of the Social Security Act). Complaints from providers and enrollees involving\nsteering should be sent to the Office of the Medicaid Inspector General (OMIG). The OMIG website contains\nonline forms for complaints which can be found at: https://www.omig.ny.gov/fraud/file-an-allegation.\n*****************************************************************", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0012", "char_start": 21000, "char_end": 23000, "pages": [8, 9], "text": "t to the Office of the Medicaid Inspector General (OMIG). The OMIG website contains\nonline forms for complaints which can be found at: https://www.omig.ny.gov/fraud/file-an-allegation.\n*******************************************************************************************************************\nBreastfeeding Grand Rounds 2019: Breastfeeding Recommendations\nfor Women Impacted by Opioid Use Disorder and\nInfants with Neonatal Abstinence Syndrome\nBreastfeeding Grand Rounds (BFGR) 2019 will air on August 1, 2019 from 8:30 a.m. – 10:30 a.m. The 2019\nBFGR live webcast will discuss the prevalence of Opioid Use Disorder (OUD) among pregnant women and\nneonatal abstinence syndrome (NAS) in infants. Health professionals, women, and their families should\nunderstand that breastfeeding can play a key role in the treatment of NAS by decreasing its duration and severity.\nThis webcast will provide resources for identifying pregnant, breastfeeding, and post-partum women with OUD,\nstrategies and tools to facilitate a discussion, and approaches to refer individuals to the most appropriate options\nfor support and follow up.\nThis webcast is intended for local and state public health and healthcare professionals, paraprofessionals,\nclinicians (physicians, midwives, healthcare providers, nurses, registered dietitians), and lactation specialists\nand will offer Continuing Medical Education (CME), Continuing Nursing Education (CNE), Certified Health\nEducation Specialist (CHES), Lactation Continuing Education Recognition Points (LCERP), or general\ncontinuing education credits. More information, including previous years’ BFGR webcasts and registration\ninformation for the 2019 BFGR webcast, can be found at: http://www.albany.edu/sph/cphce/bfgr.shtml.\n*******************************************************************************************************************\nJune 2019 New York State Medicaid Update pg. 8\n\n2019 Medicaid Managed Care Primary Care Providers:\nAccess and Availability\nPrimar", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0013", "char_start": 22750, "char_end": 24750, "pages": [8, 9], "text": "tml.\n*******************************************************************************************************************\nJune 2019 New York State Medicaid Update pg. 8\n\n2019 Medicaid Managed Care Primary Care Providers:\nAccess and Availability\nPrimary Care Providers (PCPs) (Family Practice, Internal Medicine, Obstetrics/Gynecology (OB/GYN),\nPediatricians) who contract with Medicaid Managed Care (MMC) Plans must meet specific appointment and\navailability standards to ensure that enrolled Medicaid members have appropriate access to necessary health\ncare. New York State routinely completes surveillance activities to evaluate compliance with the following\nappointment availability standards, (Medicaid Model Contract 15.2, Appointment Availability Standards):\n• For urgent care: within twenty-four (24) hours of request.\n• Non-urgent “sick” visit: within forty-eight (48) to seventy-two (72) hours of request, as clinically indicated.\n• Routine non-urgent, preventive appointments except as otherwise provided in this Section: within four\n(4) weeks of request.\n• Initial prenatal visit: within three (3) weeks during first trimester, within two (2) weeks during the second\ntrimester and within one (1) week during the third trimester.\n• Adult baseline and routine physicals: within twelve (12) weeks from enrollment.\n• Well child care: within four (4) weeks of a request;\n• Initial family planning visits: within two (2) weeks of request.\n• Members must reach a live voice when calling a provider after-hours (i.e., an answering service).\nMMC Plans must require contracted PCPs and OB/GYNs to have the primary responsibility serving as the after-\nhours “on-call” telephone resource to members with medical problems. Providers should not routinely refer calls\nto an emergency room, unless the Medicaid member is experiencing a life-threatening health emergency.\nPlease Note: Providers are required to schedule appointments in accordance with appointment and availability\nstandards noted above to b", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0014", "char_start": 24500, "char_end": 26500, "pages": [9, 10], "text": " refer calls\nto an emergency room, unless the Medicaid member is experiencing a life-threatening health emergency.\nPlease Note: Providers are required to schedule appointments in accordance with appointment and availability\nstandards noted above to be determined compliant with access to care requirements when contacted by an\nMMC Plan member. Providers must not require a new patient to complete prerequisites to schedule an\nappointment, such as:\n• a copy of their medical record;\n• a health screening questionnaire; and/or\n• an immunization record.\nThe provider may request additional information from the new Medicaid member, if the appointment is scheduled\nat the time of the telephone request. The Department considers prerequisites to scheduling appointments as\nbarriers in gaining access to health care services. Medicaid PCPs are advised to contact the MMC Plan if they\nare having difficulty meeting the above appointment and availability standards.\nQuestions may be sent to the Office of Health Insurance Programs (OHIP), Division of Health Plan Contracting\nand Oversight, Bureau of Managed Care Certification and Surveillance at: BMCCSmail@health.ny.gov.\n*******************************************************************************************************************\nJune 2019 New York State Medicaid Update pg. 9\n\nNew York Medicaid EHR Incentive Program\nDistribution to Eligible Professionals & Eligible Hospitals Since the Start of the Program in 2011*\nNumber of Payments: Distributed Funds:\n39,045 $972,441,858\n*As of 6/10/2019\nThrough the New York (NY) Medicaid Electronic Health Record (EHR) Incentive Program eligible professionals\n(EPs) and eligible hospitals (EHs) in NY who adopt, implement, or upgrade certified EHR technology (CEHRT)\nand subsequently become meaningful users of CEHRT, can qualify for financial incentives. The Centers for\nMedicare and Medicaid Services (CMS) is dedicated to improving interoperability and patient access to health\ninformation. The NY Medicai", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0015", "char_start": 26250, "char_end": 28250, "pages": [10], "text": " (CEHRT)\nand subsequently become meaningful users of CEHRT, can qualify for financial incentives. The Centers for\nMedicare and Medicaid Services (CMS) is dedicated to improving interoperability and patient access to health\ninformation. The NY Medicaid EHR Incentive Program is a part of the CMS Promoting Interoperability Program\nbut will continue to operate under the current name, NY Medicaid EHR Incentive Program.\nMEIPASS Opening Date for Payment Year 2018\nThe Medicaid EHR Incentive Program Administrative Support Service (MEIPASS) opens for Payment Year\n(PY) 2018 Attestations on July 1, 2019. The deadline to attest for PY 2018 is September 30, 2019. To attest for\nPY 2018 in MEIPASS starting on July 1, 2019 please visit: https://meipass.emedny.org/ehr/login.xhtml.\nGreenway Health LLC Products\nGreenway Health LLC identified that certain EHR products are calculating Promoting Interoperability (Meaningful\nUse) measures incorrectly, and they are working on fixing these issues. Providers who used any of the impacted\nGreenway products in 2019 should complete the “Greenway Health LLC Identification Form.” This form is\navailable to download in Microsoft Excel format at:\nhttps://www.health.ny.gov/health_care/medicaid/redesign/ehr/repository/docs/greenway_form.xlsx. Completed\nforms can be submitted as an attachment via email to attenstation@health.ny.gov.\nNew York State (NYS) Regional Extension Centers (RECs)\nNYS RECs offer free support to help providers achieve Meaningful Use of CEHRT. Support provided by\nNYS RECs includes but is not limited to: answers to questions regarding the program and requirements,\nassistance on selecting and using CEHRT, or help meeting program objectives. NYS RECs offer free assistance\nfor all practices and providers located within New York.\nProviders located inside the five boroughs of New York City (NYC) should contact:\nNYC REACH\nPhone: 1-347-396-4888\nWebsite: https://www.nycreach.org.\nEmail: pcip@health.nyc.gov.\nProviders located outside the five ", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0016", "char_start": 28000, "char_end": 30000, "pages": [10, 11, 12], "text": "nd providers located within New York.\nProviders located inside the five boroughs of New York City (NYC) should contact:\nNYC REACH\nPhone: 1-347-396-4888\nWebsite: https://www.nycreach.org.\nEmail: pcip@health.nyc.gov.\nProviders located outside the five boroughs of NYC should contact:\nNew York eHealth Collaborative (NYeC)\nPhone: 1-646-619-6400\nWebsite: https://www.nyehealth.org\nEmail: ep2info@nyehealth.org\nWebinars and Q&A Sessions\nA calendar with the date and times of upcoming webinars, as well as registration information, can be found at:\nhttps://www.health.ny.gov/health_care/medicaid/redesign/ehr/calendar/.\nNY Medicaid EHR Incentive Program Post-Payment Audit Education Series\nNY Medicaid EHR Incentive Program has produced a series of Post-Payment Audit Educational tutorials to\nassist providers for preparation in the event of a post-payment audit. Links to available tutorials can be found\nat: https://www.health.ny.gov/health_care/medicaid/redesign/ehr/audit/.\nJune 2019 New York State Medicaid Update pg. 10\n\nQuestions\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at:\n1-877-646-5410 (Option 2) or via email at: hit@health.ny.gov.\nPlease Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey\nThe NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\n*******************************************************************************************************************\nJune 2019 New York State Medicaid Update pg. 11\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud or abuse complaints/allegations, call 1-877-87FRAUD, (877) 873-7283, or visit\nwww.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at https://www.emedny.org/.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (av", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0017", "char_start": 29750, "char_end": 31353, "pages": [12], "text": "y.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at https://www.emedny.org/.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nTo sign up for a provider seminar, please enroll online at https://www.emedny.org/training/index.aspx. For\nindividual training requests, call (800) 343-9000.\nBeneficiary Eligibility:\nCall the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following websites:\nhttp://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-educationprog\nhttp://nypep.nysdoh.suny.edu/home\neMedNY\nFor a number of services including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment please visit: https://www.emedny.org/\ninfo/ProviderEnrollment/index.aspx and choose the appropriate link based on provider type.\nMedicaid Electronic Health Record (EHR) Incentive Program questions?\nContact the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication?\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nJune 2019 New York State Medicaid Update pg. 12", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0018", "char_start": 31103, "char_end": 31353, "pages": [12], "text": " the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication?\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nJune 2019 New York State Medicaid Update pg. 12", "chunk_type": "text"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0019::table", "char_start": null, "char_end": null, "pages": [7], "text": "(b) The practitioner must notify the individuals designated under §1311.125 or §1311.130 within\r\n\"one business day of discovery that the hard token has been lost, stolen, or compromised or the\"\r\nauthentication protocol has been otherwise compromised. A practitioner who fails to comply with\r\nthis provision may be held responsible for any controlled substance prescriptions written using\r\nhis two-factor authentication credential.\r\n\"\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0020::table", "char_start": null, "char_end": null, "pages": [10], "text": ",Number of Payments:,,,Distributed Funds:,\r\n\"39,045\",,,\"$972,441,858\",,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0021::table", "char_start": null, "char_end": null, "pages": [10], "text": "The Medicaid EHR Incentive Program Administrative Support Service (MEIPASS) opens for Payment Year\r\n\"(PY) 2018 Attestations on July 1, 2019. The deadline to attest for PY 2018 is September 30, 2019. To attest for\"\r\n\"PY 2018 in MEIPASS starting on July 1, 2019 please visit:\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0022::table", "char_start": null, "char_end": null, "pages": [11], "text": "Questions\r\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at:\r\n1-877-646-5410 (Option 2) or via email at: hit@health.ny.gov.\r\n", "chunk_type": "table"}
{"doc_id": "mu_no07_jun19_pr.pdf", "chunk_id": "mu_no07_jun19_pr.pdf::0023::table", "char_start": null, "char_end": null, "pages": [11], "text": ",Please Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey,\r\n\"The NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\",,\r\n", "chunk_type": "table"}
